SMC lanserar ny elektrisk cylinder för livsmedelsindustrin

Nya HF2A-LEY är framtagen för att möta kraven inom livsmedelsindustrin och passar perfekt i maskiner som utsätts för regelbunden desinfektion och rengöring. Cyl...

Emerson

Thomas Eldered: ”Innovation is the key”

Thomas Eldered speaks in a web clip about the challenges facing the life science sector in the future and what he, as an investor, finds most interesting in new companies.

The US is leaving the WHO

The newly installed US President, Donald Trump, has issued an executive order for the US to leave the World Health Organization, WHO.

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

Optimize Your Visibility

ZEISS presents our newest VersaXRM® 730 3D X-ray microscope.

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

The first drugs to slow down Alzheimer’s – but what does it mean for patients?

New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...

Forskare ifrågasätter tidskriftssystemet: ”En prestigeekonomi”

Rovtidskrifter rotar sig i ett mycket bredare problem med opålitliga kvalitetsmått och förskönade uppfattningar om anseende. Det menar KI-forskaren Gustav Nilso...

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Automated dispensing

Are you interested in automated dispensing of liquids?

Thumbs down for lecanemab in the EU – “Very surprised”

The Azheimer's drug lecanemab has received a negative assessment from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), acc...

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

Easy integration of piezo valves for gas handling

Extremely energy-saving, silent and without any heat build-up – piezo technology offers many benefits for efficient and precise gas handling in medical technolo...

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Healthcare study: Alzheimer’s blood test shows high accuracy

A blood test for identifying Alzheimer’s has now been tested in the general healthcare setting. According to the researchers, the test was 90% accurate in making a diagnosis.

On the hunt for high throughput diagnostics

Global diagnostics companies and laboratories are in a race against time to adapt testing capacity to current demand. Due to the global COVID 19 pandemic, the d...

Noxious parasite forms hybrids and deceives the immune system

The small parasite Trypanosoma cruzi has a nasty ability to cause serious illness. Researchers at the Karolinska Institutet have now mapped its ability to deceive the immune system...

Accelerate your Research with AI-Powered Image Analysis

Comprehensive eBook from ZEISS.

Radiofarmakabolaget Aktis tar in miljardbelopp

Amerikanska biotechbolaget Aktis Oncology, som utvecklar radiofarmaka, tar in 175 miljoner amerikanska dollar, motsvarande cirka 1,8 miljarder svenska kronor, g...

Swedish pavilion with healthcare companies at Ukraine fair – “Ukraine is being rebuilt right now”

Private companies and public authorities are both needed in the reconstruction of Ukraine, said Minister for Health Care, Acko Ankarberg Johansson, in her openi...